US SEC subpoenas Lilly in widened probe of compliance with overseas antibribery law
25 February 2010
Nancy Faigen
Please Login to read the full article.
25 February 2010
Nancy Faigen
In its latest regulatory filing,
Lilly has reported new developments regarding a widened probe by the US Department of Justice (DoJ) and the US Securities and Exchange Commission (SEC) that it had first revealed in February 2009. The issue relates to its subsidiaries' compliance with...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Federal shutdown averted, but spending reductions could spell trouble for expensive drugs
- US Capitol Capsule: NIH confesses error on unapproved drugs, but sets no deadline for changes
- FDA chemist charged with insider trading after hauling in $3.6 million
- Merck paying $950 million to settle US Vioxx criminal, civil charges
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
